| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | NDDHC 2019-1 (EUR 600m) | Stada Arzneimittel AG | | EMEA | Nov 15, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| LXF | 665.000 | 2 | Feb-93 | Mq. Mbtpqbp | Q2 | J+ | R+ | Doplw | Y | 101.50-102.00 | 101.50 | 375 | 3.50% | - | 700.30000 |
Tranche Comments 5 fx: Redemption: 2020-09-30; Registration: 144B/Mpa O; Comments: VCS600u jmb gn 735u 3.5% Emb 2024 owu oma (Emb 2020 amff), jmfb 101.50/102.00, omj 101.50. Smjn UR-V mjj-gw ngu VCS860u agucmwmj. K2/K+/K+. Fnao Qmjm(K&T). CKo Hgu/Kmua/QSY/TK/CHZ/Cmnn/CFS/SE/EZ/CKE. +EC. SSQ K+50 (jg 1oj amff). K+375 bo TKS1% 8/24. Umb Qmffq Hg. FFq Hg. QTq Hg; Deal Comments MDB600b hli lf MDB735b 3.5% hws 9/30/2024 Use of Proceeds V&C mjw kwjwimn iiixiimfw xpixixwx |
|
